ANVS
Price
$4.65
Change
+$0.24 (+5.44%)
Updated
Dec 3 closing price
Capitalization
123.24M
109 days until earnings call
Intraday BUY SELL Signals
BDTX
Price
$2.69
Change
-$0.76 (-22.03%)
Updated
Dec 3 closing price
Capitalization
152.69M
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANVS vs BDTX

Header iconANVS vs BDTX Comparison
Open Charts ANVS vs BDTXBanner chart's image
Annovis Bio
Price$4.65
Change+$0.24 (+5.44%)
Volume$1.36M
Capitalization123.24M
Black Diamond Therapeutics
Price$2.69
Change-$0.76 (-22.03%)
Volume$10.18M
Capitalization152.69M
ANVS vs BDTX Comparison Chart in %
ANVS
Daily Signal:
Gain/Loss:
BDTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANVS vs. BDTX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Hold and BDTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ANVS: $4.43 vs. BDTX: $3.45)
Brand notoriety: ANVS and BDTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 42% vs. BDTX: 95%
Market capitalization -- ANVS: $123.24M vs. BDTX: $152.69M
ANVS [@Biotechnology] is valued at $123.24M. BDTX’s [@Biotechnology] market capitalization is $152.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green whileBDTX’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • BDTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ANVS is a better buy in the long-term than BDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 6 TA indicator(s) are bullish while BDTX’s TA Score has 2 bullish TA indicator(s).

  • ANVS’s TA Score: 6 bullish, 4 bearish.
  • BDTX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than BDTX.

Price Growth

ANVS (@Biotechnology) experienced а -8.12% price change this week, while BDTX (@Biotechnology) price change was -10.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

ANVS is expected to report earnings on Mar 23, 2026.

BDTX is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDTX($153M) has a higher market cap than ANVS($123M). BDTX YTD gains are higher at: 61.215 vs. ANVS (-11.952). BDTX has higher annual earnings (EBITDA): 5.05M vs. ANVS (-23.68M). BDTX has more cash in the bank: 143M vs. ANVS (17.1M). BDTX has higher revenues than ANVS: BDTX (70M) vs ANVS (0).
ANVSBDTXANVS / BDTX
Capitalization123M153M80%
EBITDA-23.68M5.05M-469%
Gain YTD-11.95261.215-20%
P/E RatioN/A7.27-
Revenue070M-
Total Cash17.1M143M12%
Total DebtN/A20.8M-
FUNDAMENTALS RATINGS
ANVS vs BDTX: Fundamental Ratings
ANVS
BDTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
10062
PRICE GROWTH RATING
1..100
3439
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
35n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANVS's Valuation (50) in the null industry is in the same range as BDTX (56). This means that ANVS’s stock grew similarly to BDTX’s over the last 12 months.

ANVS's Profit vs Risk Rating (98) in the null industry is in the same range as BDTX (100). This means that ANVS’s stock grew similarly to BDTX’s over the last 12 months.

BDTX's SMR Rating (62) in the null industry is somewhat better than the same rating for ANVS (100). This means that BDTX’s stock grew somewhat faster than ANVS’s over the last 12 months.

ANVS's Price Growth Rating (34) in the null industry is in the same range as BDTX (39). This means that ANVS’s stock grew similarly to BDTX’s over the last 12 months.

BDTX's P/E Growth Rating (98) in the null industry is in the same range as ANVS (100). This means that BDTX’s stock grew similarly to ANVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANVSBDTX
RSI
ODDS (%)
Bearish Trend 7 days ago
72%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
73%
Momentum
ODDS (%)
Bullish Trend 7 days ago
84%
Bearish Trend 7 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 7 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
83%
Bearish Trend 7 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
89%
Aroon
ODDS (%)
Bullish Trend 7 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signal:
Gain/Loss:
BDTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BOUYF48.49N/A
N/A
Bouygues SA
RSGUF4.32N/A
N/A
Rogers Sugar Inc.
WKCMF77.00N/A
N/A
Wacker Chemie AG
TGAAF9.12N/A
N/A
Target Global Acquisition I Corp.
FTIDF0.18N/A
N/A
FTI Foodtech International, Inc.

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-1.80%
ADXN - ANVS
43%
Loosely correlated
-1.83%
ERAS - ANVS
37%
Loosely correlated
-3.50%
ALGS - ANVS
37%
Loosely correlated
+0.11%
RXRX - ANVS
37%
Loosely correlated
-0.69%
BDTX - ANVS
37%
Loosely correlated
-8.49%
More

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with RLAY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-8.49%
RLAY - BDTX
50%
Loosely correlated
+1.22%
CRBU - BDTX
48%
Loosely correlated
-0.56%
VYGR - BDTX
47%
Loosely correlated
-4.89%
KURA - BDTX
45%
Loosely correlated
-2.53%
CLDX - BDTX
44%
Loosely correlated
+2.85%
More